N/A N=37 A Pilot Study: Snacking, Willpower and Glucose Availability
Willpower
Primary: Responses to the Control of Eating Questionnaire — 4.5; 5.2; 5.1; 5.2 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=23 Aldosterone and Glucose Homeostasis
Diabetes Mellitus
Primary: Insulin Secretion — 48.9; 37.6; 51.8; 34.4 uU/mL
N/A N=13 Dark Chocolate and Glucose Levels in Diabetes
Type 2 Diabetes · Type 1 Diabetes
Primary: Blood Glucose Incremental Area Under the Curve — 240.5; 83.81 mM x 120 minutes
Phase 2 N=10 Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 Tesla
Type 1 Diabetes
Primary: Brain Glycogen Turnover Rate — 0.31; 0.28 mg/kg/min
N/A N=10 Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study A
Diabetes Mellitus, Type 1
Primary: Glutathione Concentration — 541; 551 umol/L
Phase 2 N=83 IV Glucose for Dehydration Treatment
Dehydration
Primary: Measurement of Serum Ketones Before and After Administration of Intravenous Fluids for Acute Gastroenteritis — 1.10; 2.39 mmol/L — p=0.0003
N/A N=7 The Impact of the Physiological Response to Sugar on Brain Activity and Behavior
Food Preferences · Appetitive Behavior
Primary: Change in Preference- Subjective Liking Ratings for Each Beverage on a Scale — -12.8; -12.0; -12.6 units on a scale
Phase 1 N=22 Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans
Insulin Resistance, Diabetes
Primary: Percentage Change in Area Under The Curve (AUC) for Blood Glucose 0-2 Hours — 301.09; 258.66; 248.63; 274.13 mmol x min/L — p=0.1146
Phase 3 N=12 The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans
Healthy
Primary: Endogenous Glucose Production (EGP) — 4.99; 5.02; 6.82; 5.52 umol/kg/min
Phase 1 N=14 Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)
Glucose Transporter Type 1 Deficiency Syndrome · GLUT1 Deficiency Syndrome
Primary: Number of Participants With Reduction in Spike-wave Fraction of the EEG Recording Time — 13 Participants
Phase 2 N=74 Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Congestive Heart Failure · Diabetes Mellitus
Primary: Hospital Length of Stay — 7; 8 days
N/A N=40 Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study B
Diabetes Mellitus, Type 1
Primary: Glutathione Concentration — 706; 734 umol/L
Phase 2 N=57 Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes
Diabetes, Gestational
Primary: Correlation Between Glucose AUC and Birth Weight. — 0.2902; 0.2935; 0.2915; 0.2859 correlation coefficient — p=0.035
N/A N=14 Effects of Added D-fagomine on Glycaemic Responses to Sucrose
Reduction of Post-prandial Glycaemic Response
Primary: Postprandial Glycaemic Response Index — 73.28; 83.45 percentage of AUC fagomine/AUC control — p=<0.0001
Phase 2 N=74 Intensive Glycemic Control for Congestive Heart Failure Exacerbation
Congestive Heart Failure · Diabetes Mellitus
Primary: Hospital Length of Stay — 7; 8 days
Phase 4 N=5 Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients
Hepatitis B
Primary: Differences in Blood Glucose Levels as Measured by GNS-POC, GS-POC and Venous Blood Prior to and After HBIG Injection — -3.2; 6.0; 56.6; -2.6 mg/dL — p=0.59
Phase 2 N=74 Glucose Regulation in Acute Stroke Patients (GRASP) Study
Stroke · Hyperglycemia
Primary: Hypoglycemic Events — 7; 1; 1 participants
Phase 2 N=30 Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance
Impaired Glucose Tolerance
Primary: Fasting Plasma Glucose (FPG) — 5.8; 5.5 mmol/L — p=0.004
Phase 2 N=45 Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)
GLUT1DS1 · Epilepsy · Glut1 Deficiency Syndrome 1, Autosomal Recessive
Primary: Neuropsychological Score of Sustained Attention — 11 Participants
N/A N=27 Erythrocyte and Adipocyte G6PD Activity Levels in Obesity
Diabetes · Obesity
Primary: Measure Erythrocyte G6PD Levels in Diabetic vs. Non-diabetic Morbidly Obese Patients Undergoing Laparoscopic Gastric Bypass. — 3.12; 0.67; 22; 13 nM/min/mg — p=<0.05
N/A N=1,939 Opportunistic Screening for Prediabetes and Early Diabetes in Primary Care
Type 2 Diabetes Mellitus · Prediabetic State
Primary: Ability of Different Screening Tests Which Can be Performed Opportunistically (During Outpatient Visits -- at Any Time of Day, Regardless of Meal Status) to Predict…
Phase 2 N=10 Almond Butter and Fasting Glucose
Type2 Diabetes
Primary: Fasting Glucose Measured Using Continuous Glucose Monitoring — 148.6; 142.1 mg/dL
N/A N=34 Effect of Dialysis Glucose Bath on Glycemic Control in Hemodialysis (HD)
Diabetes Type 2
Primary: Hemoglobin A1c Levels — 7.1; 7.1 percent — p=0.67
Early Phase 1 N=10 Investigation of the Glycemic Index of Ethiopian Honey
Hyperglycemia, Postprandial
Primary: Examine Effect of Monofloral Honey Types on Glycemic Index of Health Human Subjects — 54.73; 62.82; 60.31; 59.54 Index — p=<0.01
Phase 2 N=20 An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
Primary: Reported Change in Seizures Frequency From Baseline at 13 Weeks — 4.4; 189.5 seizures/two weeks
N/A N=15 The Acute Effects of Food Structure on Post Prandial Glucose and Subsequent Metabolic Responses
Obesity
Primary: Post-prandial Glucose Concentrations — 4.9; 4.8; 4.9; 5.01 mmol/l
N/A N=6 Determination of the Glycemic Index and the Insulinemic Index of a Sweetener Syrup
Healthy Volunteers
Primary: Glycemic Index — 100; 33.68; 12.83 % of GI of the glucose
N/A N=15 Glucose Measurement Using Microneedle Patches
Diabetes
Primary: Glucose Level — 137; 174.5; 160.9; 155 mg/dL
N/A N=12 Glycemic Response Testing
Glycemic Index · Glycemic Response
Primary: Glycemic Response Measured as the Positive Incremental Area Under the Time-concentration Curve(iAUC) Calculated From Individual Glucose Measurements Upon Consumption of…
N/A N=297 Blood Glucose Testing and You
Diabetes
Primary: Percent of Subjects Outside Specified Blood Glucose (BG) Range -Estimated Versus Measured Blood Glucose — 45.80 percentage of subjects